AbbVie Inc. (ABBV34)
Bovespa
Closed
Aug 24, 2026
Day's Range
84.7252 wk Range
58.81Overview - ABBV34 - AbbVie Inc.
Key Statistics
Valuation
Enterprise Value
1.10T
P/E (Trailing)
‪74.19‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪37.46‬
Price / Book
‪-408.60‬
EV / EBITDA
‪6.99‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0020%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪79.74‬
200-Day Avg
‪73.68‬
Dividends
Payout Ratio
‪132.05%‬
Frequency
Quarterly
Peers - ABBV34 - AbbVie Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Bovespa.
Profile Summary - ABBV34 - AbbVie Inc.
About
AbbVie Inc. is a prominent biopharmaceutical company dedicated to the research, development, and distribution of innovative medicines and treatments globally. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on addressing complex and serious health conditions, with core areas of expertise in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
